Your browser doesn't support javascript.
loading
Long-term Treatment With Ponesimod in Relapsing-Remitting Multiple Sclerosis: Results From Randomized Phase 2b Core and Extension Studies.
Freedman, Mark S; Pozzilli, Carlo; Havrdova, Eva Kubala; Lemle, Alexandre; Burcklen, Michel; Larbalestier, Anna; Hennessy, Brian; Sidorenko, Tatiana; Vaclavkova, Andrea; Olsson, Tomas.
Afiliación
  • Freedman MS; From the Multiple Sclerosis Research Unit, Department of Medicine, The University of Ottawa; The Ottawa Hospital Research Institute, Ontario, Canada (M.S.F.); Department of Human Neuroscience, Sapienza University of Rome, Italy (C.P.); Department of Neurology, First Medical Faculty, Charles Universi
  • Pozzilli C; From the Multiple Sclerosis Research Unit, Department of Medicine, The University of Ottawa; The Ottawa Hospital Research Institute, Ontario, Canada (M.S.F.); Department of Human Neuroscience, Sapienza University of Rome, Italy (C.P.); Department of Neurology, First Medical Faculty, Charles Universi
  • Havrdova EK; From the Multiple Sclerosis Research Unit, Department of Medicine, The University of Ottawa; The Ottawa Hospital Research Institute, Ontario, Canada (M.S.F.); Department of Human Neuroscience, Sapienza University of Rome, Italy (C.P.); Department of Neurology, First Medical Faculty, Charles Universi
  • Lemle A; From the Multiple Sclerosis Research Unit, Department of Medicine, The University of Ottawa; The Ottawa Hospital Research Institute, Ontario, Canada (M.S.F.); Department of Human Neuroscience, Sapienza University of Rome, Italy (C.P.); Department of Neurology, First Medical Faculty, Charles Universi
  • Burcklen M; From the Multiple Sclerosis Research Unit, Department of Medicine, The University of Ottawa; The Ottawa Hospital Research Institute, Ontario, Canada (M.S.F.); Department of Human Neuroscience, Sapienza University of Rome, Italy (C.P.); Department of Neurology, First Medical Faculty, Charles Universi
  • Larbalestier A; From the Multiple Sclerosis Research Unit, Department of Medicine, The University of Ottawa; The Ottawa Hospital Research Institute, Ontario, Canada (M.S.F.); Department of Human Neuroscience, Sapienza University of Rome, Italy (C.P.); Department of Neurology, First Medical Faculty, Charles Universi
  • Hennessy B; From the Multiple Sclerosis Research Unit, Department of Medicine, The University of Ottawa; The Ottawa Hospital Research Institute, Ontario, Canada (M.S.F.); Department of Human Neuroscience, Sapienza University of Rome, Italy (C.P.); Department of Neurology, First Medical Faculty, Charles Universi
  • Sidorenko T; From the Multiple Sclerosis Research Unit, Department of Medicine, The University of Ottawa; The Ottawa Hospital Research Institute, Ontario, Canada (M.S.F.); Department of Human Neuroscience, Sapienza University of Rome, Italy (C.P.); Department of Neurology, First Medical Faculty, Charles Universi
  • Vaclavkova A; From the Multiple Sclerosis Research Unit, Department of Medicine, The University of Ottawa; The Ottawa Hospital Research Institute, Ontario, Canada (M.S.F.); Department of Human Neuroscience, Sapienza University of Rome, Italy (C.P.); Department of Neurology, First Medical Faculty, Charles Universi
  • Olsson T; From the Multiple Sclerosis Research Unit, Department of Medicine, The University of Ottawa; The Ottawa Hospital Research Institute, Ontario, Canada (M.S.F.); Department of Human Neuroscience, Sapienza University of Rome, Italy (C.P.); Department of Neurology, First Medical Faculty, Charles Universi
Neurology ; 99(8): e762-e774, 2022 08 23.
Article en En | MEDLINE | ID: mdl-35667837
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Esclerosis Múltiple Recurrente-Remitente / Esclerosis Múltiple Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Neurology Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Esclerosis Múltiple Recurrente-Remitente / Esclerosis Múltiple Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Neurology Año: 2022 Tipo del documento: Article